APA

Paul D., Vukelja S. J., Ann Holmes F., Blum J. L., McIntyre K. J., Lindquist D. L., Osborne C. R., Sanchez I. J., Goldschmidt J. H., Wang Y., Asmar L., Strauss L. & O'Shaughnessy J. (2019). Randomized phase-II evaluation of letrozole plus dasatinib in hormone receptor positive metastatic breast cancer patients. : NPJ breast cancer.

Chicago

Paul Devchand, Vukelja Svetislava J, Ann Holmes Frankie, Blum Joanne L, McIntyre Kristi J, Lindquist Deborah L, Osborne Cynthia R, Sanchez Ines J, Goldschmidt Jerome H, Wang Yunfei, Asmar Lina, Strauss Lewis and O'Shaughnessy Joyce. 2019. Randomized phase-II evaluation of letrozole plus dasatinib in hormone receptor positive metastatic breast cancer patients. : NPJ breast cancer.

Harvard

Paul D., Vukelja S. J., Ann Holmes F., Blum J. L., McIntyre K. J., Lindquist D. L., Osborne C. R., Sanchez I. J., Goldschmidt J. H., Wang Y., Asmar L., Strauss L. and O'Shaughnessy J. (2019). Randomized phase-II evaluation of letrozole plus dasatinib in hormone receptor positive metastatic breast cancer patients. : NPJ breast cancer.

MLA

Paul Devchand, Vukelja Svetislava J, Ann Holmes Frankie, Blum Joanne L, McIntyre Kristi J, Lindquist Deborah L, Osborne Cynthia R, Sanchez Ines J, Goldschmidt Jerome H, Wang Yunfei, Asmar Lina, Strauss Lewis and O'Shaughnessy Joyce. Randomized phase-II evaluation of letrozole plus dasatinib in hormone receptor positive metastatic breast cancer patients. : NPJ breast cancer. 2019.